KRAS and hepatocellular carcinoma: Selected gene variants were confirmed in hereditary cancer syndrome with a higher risk of resistant KRAS mutated lung adenocarcinoma, colorectal and esophageal cancers, hepatocellular carcinoma, and glioblastoma [11,45].